Fact CheckerSign in

NCT05491980Active, not recruiting

Florida Cerebrovascular Disease Biorepository and Genomics Center

Creating a Florida Cerebrovascular Disease Biorepository and Genomics Center

Source: ClinicalTrials.gov · Last updated 3 Sept 2026

Brief summary (registry, in English)

The purpose of this study is to create a state-wide biorepository and resource center for cerebrovascular diseases in Florida, which will include collecting medical history information and blood from subjects affected by cerebrovascular disease. The information and blood samples collected may be used in future research for the study of cerebrovascular disease and to learn about, prevent or treat other health problems.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
72 (actual)
First submitted
5 Aug 2022
Start date
2 Aug 2022
Primary completion date
Jun 2030
Lead sponsor
Mayo Clinic
Diseases
Stroke
NCT number
NCT05491980

What you commit to

  • Study type: Observational
  • Participants enrolled: 72
  • From 2 Aug 2022 to the primary completion date, Jun 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • All patients with the following known or suspected virulent microorganisms causing an active or latent infection will be excluded from the study:
  • Human immunodeficiency virus (HIV);
  • Any viral hepatitis;
  • Tuberculosis (TB);

Other

  • West Nile virus (WNV);
  • Influenza virus;
  • Any bacteremia;
  • Any fungemia;
  • Any prionopathy.

Who the study is looking for

  • Affected subjects with diverse cerebrovascular conditions, including, but not limited to, ischemic stroke, transient ischemic attack (TIA), intracerebral hemorrhage (ICH), aneurysmal subarachnoid hemorrhage (aSAH), vascular dementia (VAD), anoxic brain injury, unruptured intracranial aneurysm (UIA), cavernous malformation, arteriovenous malformations (AVM), carotid and vertebral arterial dissections, symptomatic and asymptomatic cervical carotid artery atherosclerotic stenosis, non-aneurysmal perimesencephalic subarachnoid hemorrhage (naSAH), cerebral venous thrombosis (CVT), moyamoya disease, fibrosmuscular dysplasia (FMD), non-traumatic, angiography-negative subarachnoid hemorrhage, leukoaraiosis, arteriovenous fistula, reversible cerebral vasoconstriction syndrome (RCVS), and CADASIL.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Mayo Clinic Florida
Coordinator of this site? Confirm its status
JacksonvilleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.